HCSC(SH:600378) Huaan Securities·2025-05-11 04:20Investment Rating - Investment Rating: Buy (Maintain) [2] Core Views - The company reported a revenue of 13.966 billion yuan in 2024, a year-on-year increase of 77.86%, and a net profit attributable to shareholders of 1.054 billion yuan, up 17.11% year-on-year [4][5] - The company has completed the acquisition of Sinochem Blue Sky, enhancing its fluorochemical industry chain and product offerings [6][7] - The high-end fluorine materials segment faced pressure due to declining prices, while the electronic chemicals and carbon reduction business saw improved gross margins [7][8] Financial Performance Summary - In Q4 2024, the company achieved a revenue of 3.759 billion yuan, a year-on-year increase of 138.14%, but a quarter-on-quarter decrease of 44.29% [4] - For Q1 2025, the company reported a revenue of 3.157 billion yuan, a year-on-year increase of 95.73%, but a quarter-on-quarter decrease of 16.02% [5] - The gross margin for Q4 2024 was 19.02%, down 14.04 percentage points year-on-year, while the net margin was 5.70%, down 7.80 percentage points year-on-year [8][10] Segment Analysis - The high-end fluorine materials segment experienced a 20.7% decline in gross profit year-on-year, while the electronic chemicals segment saw a 25.0% increase in gross profit [7] - The carbon reduction business maintained stable growth, with average prices for copper and nickel catalysts increasing by 5.4% and 12.9% year-on-year, respectively [7] Future Outlook - The company expects net profits attributable to shareholders to reach 1.242 billion yuan in 2025, 1.534 billion yuan in 2026, and 1.775 billion yuan in 2027, with corresponding P/E ratios of 26.54X, 21.49X, and 18.57X [11]